Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial
Gregory Piazza, Alex C. Spyropoulos, Judith Hsia, et al.
Circulation (2023) Vol. 147, Iss. 25, pp. 1891-1901
Open Access | Times Cited: 20

Showing 20 citing articles:

2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
Sam Schulman, Donald M. Arnold, Charlotte Bradbury, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 6, pp. 1779-1797
Open Access | Times Cited: 18
Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
Clinical implications of COVID-19 in chronic kidney disease and end-stage kidney disease
Paul Cockwell, Matthew D. Griffin
Elsevier eBooks (2025), pp. 543-568
Closed Access
What Role Does Microthrombosis Play in Long COVID?
Toshiaki Iba, Jean M. Connors, Jerrold H. Levy
Seminars in Thrombosis and Hemostasis (2023) Vol. 50, Iss. 04, pp. 527-536
Closed Access | Times Cited: 11
Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis
Stefanie Reis, Amon Faske, Ina Monsef, et al.
Thrombosis Research (2024) Vol. 238, pp. 141-150
Open Access | Times Cited: 3
Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling
Shirin Jannati, Rajashree Patnaik, Yajnavalka Banerjee
(2024)
Open Access | Times Cited: 3
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management
Richard C. Becker, Udaya S. Tantry, Muhammad H Khan, et al.
Journal of Thrombosis and Thrombolysis (2024)
Open Access | Times Cited: 2
Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysis
Cho‐Han Chiang, Omer Ahmed, Weitao Liu, et al.
Journal of Thrombosis and Thrombolysis (2024) Vol. 57, Iss. 5, pp. 784-787
Closed Access | Times Cited: 1
Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling
Shirin Jannati, Rajashree Patnaik, Yajnavalka Banerjee
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8727-8727
Open Access | Times Cited: 1
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19
Behnood Bikdeli, Darsiya Krishnathasan, Candrika D. Khairani, et al.
Thrombosis Research (2024) Vol. 237, pp. 209-215
Open Access
Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19
X. Shen, Eryue Qiu, Zhao Liu, et al.
Saudi Medical Journal (2024) Vol. 45, Iss. 4, pp. 341-348
Open Access
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs. no anticoagulation: Final analysis of the OVID randomized trial
Riccardo M. Fumagalli, Davide Voci, Behnood Bikdeli, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 5, pp. 102534-102534
Open Access
The Contribution of Neutrophil Extracellular Traps to Coagulopathy in Patients with COVID-19-Related Thrombosis
C. Enochs, Gabriela Delevati Colpo, Lucy Couture, et al.
Viruses (2024) Vol. 16, Iss. 11, pp. 1677-1677
Open Access
Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Davide Di Vece, Marco Valgimigli, Elliot S. Barnathan, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 8, pp. 102613-102613
Open Access
Prophylactic-dose direct oral anticoagulants for non-hospitalised people with COVID-19: A meta-analysis of randomised controlled trials
Qingchun Song, Hongduan Liu, Haoyu Tan, et al.
Journal of Global Health (2024) Vol. 14
Open Access
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials
Stefano Barco, Saverio Virdone, Andrea Götschi, et al.
Thrombosis Research (2023) Vol. 230, pp. 27-32
Open Access | Times Cited: 1
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials
Judith Hsia, Alex C. Spyropoulos, Gregory Piazza, et al.
Thrombosis and Haemostasis (2023) Vol. 124, Iss. 07, pp. 649-655
Open Access | Times Cited: 1
From brain fog to COVID toe: A head-to-toe review of long COVID
Jamie K. Stone, Sarah Berman, Wendy Zheng, et al.
American Journal of Pharmacotherapy and Pharmaceutical Sciences (2023) Vol. 2, pp. 12-12
Closed Access
Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection
Yan Yu, Haobin Li, Jing Liu, et al.
American Journal of Cardiovascular Drugs (2023)
Closed Access
COVID-19 und VTE-Prophylaxe
Florian Länger
Springer Reference Medizin (2023), pp. 1-11
Closed Access
Page 1

Scroll to top